Advertisement

Topics

Companies Related to "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" [Most Relevant Company Matches] - Page: 3 RSS

11:43 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Maraviroc Combination With Optimized Background Therapy Versus" Companies 51–75 of 2,200+

Probably Relevant

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology related to gene transfer and therapy and to serve as a professional adviser to the community and to the regulatory bodies in Europe.


Focus Bio-Inova, Inc.

Our project managers have many years of experience in handling the demanding requirements of specimens logistics, site support, and data management that make clinical trials a success. Focus project managers are often used by our clinical trial partners to help make their trial more efficient and cost effective. We also offer a unique Information Technology infrastructure that captures all aspects...

SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals (NASDAQ: SCLN) is a profit-driven, global specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. SciClone is focused on continuing international sales growth, a cost-containing clinical development strategy, and overall expense manage...


Proactiv

Proactiv® Solution, the world's best selling acne system, is a leader in acne prevention and treatment formulated to offer consumers the opportunity for a lifetime of smooth, clear, healthy-looking skin. Now with new micro-crystal benzoyl peroxide, Proactiv utilizes Combination Therapy® to directly target the root causes of acne – bacteria, oil ...

Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development ...

Vasomedical

Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease. The company’s core technology, EECP® therapy, provides healthcare professionals a non-invasive therapy for patients suffering from cardiovascular diseases. EECP therapy helps patients and their families lead active and productive lives. With ov...

TransPerfect Life Sciences

TransPerfect’s Trial Interactive solution provides a collaborative web-based platform for study start-up and eTMF that enables sponsors, CROs, IRBs, central laboratories, and other vendors to maintain and update clinical trial documentation in a secure online environment. With fully searchable solutions including investigator portals, Trial Interactiv...

Next Generation Clinical Research Consulting, Inc

Next Generation is a specialized CRO providing services to the Biotech and Pharma industries in clinical trial management and training. Our Specialties: Collaborations with smaller or emerging biotech and pharma companiesComplex projects and trial designsNovel productsAs a purposely small, niche CRO, Next Generation brings together expertise, creativity and personal service to meet your distinct...

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...

Provision Center for Proton Therapy

Opening in early 2014, the Provision Center for Proton Therapy will be the first of its kind in Tennessee and only the second in the Southeast. Proton therapy, the most advanced form of radiotherapy in the world, uses a single beam of high-energy protons to treat various forms of cancer. Different from conventional radiation therapy — in which beam en...

Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...

Orange Tree Employment Screening

Founded in 1990, Orange Tree Employment Services provides employment screening, background screening and drug testing services to more than 2,000 companies. Orange Tree specializes in providing its clients with the proper risk management, information integration, efficiency analysis, and security tools to make informed decisions. Orange Tree is the only sc...

Clinical Assistance Programs

Clinical Assistance Programs (CAP) is a clinical trial management organization. CAP provides site and data quality management, investigator training, and specialized compliance services to life science companies engaged in clinical trials.CAP was created to address many of the problems inherent in the clinical trial process such as site variability, data accuracy, investigator compliance, and the ...

CardioVascular BioTherapeutics, Inc.

CVBT is a biopharmaceutical company developing drug candidates with FGF-1 as its active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to a tissue or organ. The company has FDA-authorization for a Phase II trial to treat severe Coronary Heart Disease (CVBT-141H) and a Phase I trial to treat Peripheral Arterial Disease (CVBT-141C). A Phase III trial to treat der...

Neurologix

Neurologix, Inc., a leader in the development of innovative therapies for the brain and central nervous system, utilizes gene therapy and other novel technologies. The central nervous system ("CNS") is a new and particularly exciting target for gene therapy because its unique properties prevent the successful treatment of many neurological disorders by conventional means such as drug therapy and s...

Corautus Genetics

Corautus Genetics is dedicated to the clinical development of new therapies for the treatment of patients with serious diseases, including severe cardiovascular and peripheral vascular disease. Our goal is to become a world leader in introducing genetic therapy products into medical practice. In the Fall of 2004, Corautus initiated the largest trial of its kind in the United States for angina pati...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

IntelliCorp Records, Inc.

Intellicorp Records, Inc., is a provider of comprehensive background checks and employment screening solutions for businesses and nonprofit organizations. A Verisk Analytics (Nasdaq:VRSK) business, IntelliCorp is accredited through the National Association of Professional Background Screeners (NAPBS). Clients benefit from industry-leading data, easy-to-use...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...

VivoMetrics

At VivoMetrics, we collect and analyze continuous ambulatory physiologic data to enhance pharmaceutical research. Each protocol is a distinct project that can include study design support, project management, provision of LifeShirt garments and electronics, site training and administration, data processing and analysis, database management, biostatistical analysis and manuscript writing. All data ...

Massive Bio, Inc.

Massive Bio provides a comprehensive precision oncology access program to patients and enterprises – including virtual tumor board, clinical trial matching, reimbursement support and data analytics services. Massive Bio’s clinical trial matching customers are Contract Research Organizations (CROs), pharmaceutical companies and diagnostics labs. M...

Methodist Rehabilitation Hospital

The 40-bed facility offers specialized care to patients recovering from strokes; brain and spinal cord injuries; multi-trauma, neurological disorders; cardiopulmonary procedures; and complex orthopedic surgeries such as amputations, hip fractures, and joint replacements. Amenities at the 48,000-square-foot facility include a therapeutic pool; therapy gym with the latest in rehabilitative equipment...

Nuvelo

Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes several acute cardiovascular and oncology programs. The cardiovascular portfolio includes three programs: alfimeprase, a direct acting thr...

Sunshine Heart, Inc.

Sunshine Heart (ASX:SHC) is a global medical device company committed to novel cardiac and coronary therapy. The company is currently developing the C-Pulse® Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure which can be implanted using a minimally invasive procedure. C-...

Sg2

Sg2, a Vizient company, enables health care executives to make better, faster, more cost-effective strategic decisions through a unique combination of industry leading market analytics and unrivaled expertise. Visit Sg2.com for more information.


More From BioPortfolio on "Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks